Skip to content
OpenCapital
Get started

Bone Biologics BBLG Q4 2024 Annual earnings

Reported March 5, 2025 · Before market open

Diluted EPS-$0.61Beat by $0.04
EPS estimate-$0.65

Next report

Aug 13, 2026 (in a month)
EPS estimate-$0.39

Versus estimates

Diluted EPS

Q1 2026-$0.43In lineQ4 2025-$0.14Beat by $0.20Q3 2025-$0.37Beat by $0.86Q2 2025-$1.33Miss by $0.75Q1 2025-$1.92Miss by $1.44
Q4 2024-$0.61Beat by $0.04

Ask the moment Bone Biologics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Bone Biologics report Q4 2024 earnings?
Bone Biologics (BBLG) reported Q4 2024 earnings on March 5, 2025 before market open.
What were Bone Biologics's Q4 2024 revenue and EPS?
Bone Biologics reported diluted EPS of $-0.61 for Q4 2024.
Did Bone Biologics beat estimates in Q4 2024?
EPS beat the consensus estimate of $-0.65 by $0.04.
Where can I find Bone Biologics's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001493152-25-008383) directly on SEC EDGAR. The filing index links above go to sec.gov.